Skip to main content
. 2021 Dec 1;88(5):2065–2073. doi: 10.1111/bcp.15126

FIGURE 2.

FIGURE 2

Kaplan–Meier survival curves of COVID‐19 ICU patients (n = 51) treated with fluvoxamine + standard therapy in comparison to patients (n = 51) treated with standard therapy alone; HR 0.58, 95% CI (0.36–0.94, P = .027)